HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions [Phase 1]
Phase 1 trial comparing 800 mg prototype darunavir tablet bioavailability to the 400 mg commercial tablet, with low-dose ritonavir, under fa…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers [Phase 1]
A Phase I open-label study assessing the pharmacokinetics, safety and tolerability of rilpivirine (TMC278) 25 mg daily after two weeks of ef…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects [Phase 2]
A randomized, dose-ranging Phase 2 trial of Alferon LDO in asymptomatic HIV-infected subjects was terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Novel Interventions in HIV-1 Infection [Phase 1]
Phase 1 clinical trial in HIV-1 infection sponsored by Imperial College London has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers [Phase 1]
Phase 1 safety and immunogenicity study of an HIV-MAG vaccine with IL-12 and Ad35-GRIN/ENV in HIV-uninfected volunteers; the trial has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-09-02Clinical Trial Update: Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
This completed trial update from Massachusetts General Hospital reports on novel measures and theoretical approaches to pediatric antiretrov…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) [Phase 2]
Phase 2b study results for boceprevir in patients coinfected with HIV and hepatitis C, reporting safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy [NA]
This clinical trial update notes the completion of a study comparing home-based testing versus clinic-based testing to increase HIV testing …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting [Phase 4]
A Phase 4 randomized trial comparing nevirapine to ritonavir-boosted lopinavir in ART-naive adults with HIV-1 infection in a resource-limite…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Russian Labor Migrant HIV Prevention Trial [Phase 2]
A Phase 2 HIV prevention trial among Russian labor migrants has completed according to the trial registry update.
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Intervention to Retain HIV-positive Patients in Medical Care [NA]
This clinical trial evaluated an intervention aimed at improving retention of HIV-positive patients in medical care; the study is completed …
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons [Phase 3]
This update reports the completion of a Phase 3 trial testing whether HSV-2 suppression lowers HIV-1 viral levels in individuals co-infected…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men. [Phase 3]
Phase 3 trial evaluating HSV-2 suppression to reduce HIV-1 levels in men co-infected with HIV-1 and HSV-2 has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers [Phase 3]
Phase 3 clinical trial evaluating a telephone intervention to improve depression, coping, and family functioning in HIV-infected individuals…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users [Phase 3]
This report summarizes a Phase 3 clinical trial investigating cognitive behavioral therapy combined with antidepressants to reduce HIV risk …
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users [Phase 3]
Phase 3 clinical trial completed evaluating an antidepressant to reduce HIV risk behaviors in depressed intravenous drug users.
-
FDA approval · 2013-08-21FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability [NA]
This completed trial in Botswana evaluated the feasibility, safety, and acceptability of infant male circumcision as an HIV prevention strat…
-
CLINICAL_TRIALS research · 2013-08-20Clinical Trial Update: Using Implementation Intentions to Increase Safe Sex Practices in MSM [NA]
This clinical trial update describes a study testing implementation intentions to increase safe sex practices in men who have sex with men; …
-
CLINICAL_TRIALS trial_result · 2013-08-16Clinical Trial Update: Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults [Phase 4]
A Phase 4 trial evaluating immune responses to bivalent and tetravalent HPV vaccines in HIV-infected adults has completed.
-
FDA approval · 2013-08-15FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
A completed clinical trial in Mozambique assessed the effectiveness of new clinical guidelines for differentiating and managing common HIV/A…
-
FDA approval · 2013-08-12FDA Approved: TIVICAY — Original Application (ViiV Healthcare Company)
The FDA approved the original NDA for TIVICAY (dolutegravir), authorizing its use for treating HIV-1 infection. The submission was from ViiV…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 [Phase 4]
Phase 4 trial evaluating raltegravir in HIV-1 infected CD4 cells during acute/early HIV-1 was terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Increasing Viral Testing in the Emergency Department [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluated increasing viral testing in the emergency department, focusing on HIV and Hepatitis C testing …